FindTrial
Sign In

A prospective self-control research of effect of different laser treatments (595nm PDL vs 595nm+1064nm DW) for CM-AVM and suspicious AVM in early stage

A prospective self-control research of effect of different laser treatments (595nm PDL vs 595nm+1064nm DW) for CM-AVM and suspicious AVM in early stage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RCB-15007270
Enrollment
Unknown
Registered
2015-10-26
Start date
2015-10-27
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CM-AVM,AVM in early stage

Interventions

PDL Group:595nm PDL
DW Group:595nm+1064nm Double Width

Sponsors

Shanghai 9th People's Hospital Shanghai Jiaotong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1. CM-AVM patients with clear family histories; 2. Patients with enough lesions for two kinds of laser therapies; 3. By subcutaneous vascular ultrasound detection,the patients presented with suspective cm-avm or early AVM.

Exclusion criteria

Exclusion criteria: 1. Patients who are unwilling to be included; 2. Patients who do not meet the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
VAS;Photometer measurement;—

Secondary

MeasureTime frame
Vascular ultrasound;—

Countries

China

Contacts

Public ContactXiaoxi Lin
linxiaoxi@126.com+86 13701997136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026